Scalable preparation of poly(ethyleneglycol)-grafted siRNA-loaded lipid nanoparticles using a commercially available fluidic device and tangential flow filtration

被引:7
作者
Sakurai, Yu [1 ]
Hada, Tomoya [1 ]
Harashima, Hideyoshi [1 ]
机构
[1] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan
基金
日本学术振兴会;
关键词
Liposomes; nanoparticles; DNA/oligonucleotide delivery; siRNA; hepatocytes; liver; large-scale preparation; LIPOSOMAL-SIRNA; MICROFLUIDIC SYNTHESIS; DELIVERY; RNAI; THERAPEUTICS; SYSTEMS; CANCER;
D O I
10.1080/09205063.2017.1291297
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
While a number of siRNA delivery systems have been developed, the methods used in their preparation are not suitable for large-scale production. We herein report on methodology for the large-scale preparation of liposomal siRNA using a fluidic device and tangential flow filtration (TFF). A number of studies have appeared on the use of fluidic devices for preparing and purifying liposomes, but no systematic information regarding appropriate membrane type of commercially available apparatus is available. The findings reported herein indicate that, under optimized conditions, a microfluidic device and TFF can be used to produce siRNA lipid nanoparticles with the same characteristics as traditional ones'. The in vivo silencing efficiency of these lipid nanoparticles in the liver was comparable to laboratory-produced nanoparticles. In addition, con-focal laser scanning microscopy analyses revealed that they accumulated in the liver accumulation at the same levels as particles produced by batch-type and continuous-type procedures. This methodology has the potential to contribute to the advancement of this process from basic research to clinical studies of liposomal DDS.
引用
收藏
页码:1086 / 1096
页数:11
相关论文
共 24 条
[1]   Liposomal drug delivery systems: From concept to clinical applications [J].
Allen, Theresa M. ;
Cullis, Pieter R. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :36-48
[2]   Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA [J].
Belliveau, Nathan M. ;
Huft, Jens ;
Lin, Paulo J. C. ;
Chen, Sam ;
Leung, Alex K. K. ;
Leaver, Timothy J. ;
Wild, Andre W. ;
Lee, Justin B. ;
Taylor, Robert J. ;
Tam, Ying K. ;
Hansen, Carl L. ;
Cullis, Pieter R. .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2012, 1 :e37
[3]   Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications [J].
Capretto, Lorenzo ;
Carugo, Dario ;
Mazzitelli, Stefania ;
Nastruzzi, Claudio ;
Zhang, Xunli .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (11-12) :1496-1532
[4]   Upregulation of the Coagulation Factor VII Gene during Glucose Deprivation Is Mediated by Activating Transcription Factor 4 [J].
Cronin, Katherine R. ;
Mangan, Thomas P. ;
Carew, Josephine A. .
PLOS ONE, 2012, 7 (07)
[5]   Chemistry and formulations for siRNA therapeutics [J].
Gallas, Andrzej ;
Alexander, Cameron ;
Davies, Martyn C. ;
Puri, Sanyogitta ;
Allen, Stephanie .
CHEMICAL SOCIETY REVIEWS, 2013, 42 (20) :7983-7997
[6]   Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology [J].
Gomes-da-Silva, Ligia Catarina ;
Simoes, Sergio ;
Moreira, Joao Nuno .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2014, 71 (08) :1417-1438
[7]   Hepatic Monoacylglycerol O-acyltransferase 1 as a Promising Therapeutic Target for Steatosis, Obesity, and Type 2 Diabetes [J].
Hayashi, Yasuhiro ;
Suemitsu, Erina ;
Kajimoto, Kazuaki ;
Sato, Yusuke ;
Akhter, Afsana ;
Sakurai, Yu ;
Hatakeyama, Hiroto ;
Hyodo, Mamoru ;
Kaji, Noritada ;
Baba, Yoshinobu ;
Harashima, Hideyoshi .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2014, 3 :e154
[8]   Microfluidic remote loading for rapid single-step liposomal drug preparation [J].
Hood, R. R. ;
Vreeland, W. N. ;
DeVoe, D. L. .
LAB ON A CHIP, 2014, 14 (17) :3359-3367
[9]   Microfluidic Synthesis of PEG- and Folate-Conjugated Liposomes for One-Step Formation of Targeted Stealth Nanocarriers [J].
Hood, Renee R. ;
Shao, Chenren ;
Omiatek, Donna M. ;
Vreeland, Wyatt N. ;
DeVoe, Don L. .
PHARMACEUTICAL RESEARCH, 2013, 30 (06) :1597-1607
[10]  
Huang XM, 2010, ANTICANCER RES, V30, P463